Every individual is unique—not only at the genetic level but also in terms of physiological, environmental, and behavioral factors. This is why two individuals may respond differently to the same therapy for the same disease. Traditional healthcare has long relied on a one-size-fits-all approach, often overlooking these critical nuances of individual biology. This is where Generative AI (Gen AI), a subset of AI, steps in, bridging the gap in personalized care by converting the ever-growing amount of healthcare data into more accessible and actionable insights. Personalized healthcare, however, is more of an evolution than a revolution—progressing for the greater good of the masses.

One of the most significant contributions of Gen AI lies in its potential to speed up drug discovery by creating new molecular structures tailored to specific diseases. This process, which typically takes 10 to 15 years and costs billions of dollars, can be significantly accelerated. AI’s ability to interpret vast amounts of omics data has enabled the efficient screening of large databases to identify new drugs and biomarkers that humans might overlook. A prime example is Insilico Medicine’s revolutionary discovery of the ISM6331 molecule, generated using Gen AI, which targets solid tumors.

Another instance is Biogen’s partnership with IBM Watson Health, leveraging AI to tackle neurodegenerative diseases such as Alzheimer’s. By analyzing extensive datasets—including clinical trials and genetic information—their AI algorithms aim to identify early biomarkers, enabling earlier detection and intervention. This collaboration also uses AI to predict patient responses to treatments, personalizing therapies to individual needs and potentially slowing disease progression.

Gen AI is also being employed to analyze data from wearable devices and medical imaging (e.g., CT scans, MRIs, and X-rays). This helps radiologists detect patterns, anomalies, risks, and diseases with greater precision. Studies have shown that AI-enhanced mammography can outperform radiologists in breast cancer detection, improving both accuracy and diagnostic performance. Gen AI can also generate virtual images of human body parts, such as bones, to train medical models. However, it is crucial to thoroughly validate these AI-generated outputs to ensure accuracy and safety.

Beyond diagnostics, Gen AI can generate individualized treatment plans by factoring in medical records, lifestyle choices, and genetic data to recommend the most suitable treatments. This personalized approach increases the effectiveness of interventions. In oncology, for instance, Gen AI is being used to predict how patients will respond to cancer drugs, tailoring therapies accordingly. Additionally, Gen AI has the potential to analyze trends and patterns in patient data, making it a valuable tool for preventive care—an essential component of personalized healthcare.

Despite these advancements, challenges remain. One of the primary concerns is bias in AI models. If these models are trained on biased data, their predictions will also be biased, leading to inequities in healthcare access and outcomes. Ensuring that the data used to train AI models is representative and unbiased is critical to addressing this issue.

Another concern is the potential impact of AI on the professional dynamics within medicine. There are fears that AI could replace human healthcare providers (HCPs). While AI can undoubtedly enhance HCP performance, it is essential to remember that patient care must primarily be driven by human judgment and compassion. Patients may view AI-driven treatments with a mix of optimism and apprehension. Building trust is crucial, and this can be achieved by ensuring that AI interventions are transparent, with clear communication about how AI supports, rather than replaces, HCPs.

Also Read: Lighting the Path to Health Awareness in India: Patient-Centric Approaches to Hereditary Cancer

In summary, Gen AI offers unprecedented opportunities to transform traditional healthcare into personalized healthcare. However, achieving the full potential of Gen AI requires a balance between its applicability and ethical considerations. All stakeholders must collaborate closely—HCPs should remain at the forefront, guiding the ethical application of AI; policymakers must establish frameworks that ensure algorithm transparency, data privacy, and equitable access; and tech companies should focus on developing innovative, unbiased, and inclusive AI models.

Views expressed by: Saurav Kasera, Co-founder and CEO, CLIRNET and DocTube.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.